0001225208-17-003495.txt : 20170216 0001225208-17-003495.hdr.sgml : 20170216 20170216060145 ACCESSION NUMBER: 0001225208-17-003495 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170213 FILED AS OF DATE: 20170216 DATE AS OF CHANGE: 20170216 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: JOHNSON & JOHNSON CENTRAL INDEX KEY: 0000200406 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 221024240 STATE OF INCORPORATION: NJ FISCAL YEAR END: 0101 BUSINESS ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 BUSINESS PHONE: 732-524-2455 MAIL ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ullmann Michael H CENTRAL INDEX KEY: 0001537710 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-03215 FILM NUMBER: 17616372 MAIL ADDRESS: STREET 1: JOHNSON & JOHNSON STREET 2: ONE JOHNSON & JOHNSON PLAZA CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 4 1 doc4.xml X0306 4 2017-02-13 0000200406 JOHNSON & JOHNSON JNJ 0001537710 Ullmann Michael H ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933 1 Exec VP, General Counsel Common Stock 2017-02-13 4 M 0 14600.0000 0 A 114865.8820 D Common Stock 2017-02-13 4 A 0 5825.0000 0.0000 A 120690.8820 D Common Stock 2017-02-13 4 F 0 10591.0000 115.6700 D 110099.8820 D Common Stock 222.0000 I By 401k Common Stock 1287.0000 I By ESOP Employee Stock Options (Right to Buy) 115.6700 2017-02-13 4 A 0 71733.0000 0.0000 A 2020-02-14 2027-02-13 Common Stock 71733.0000 71733.0000 D Performance Share Units 2017-02-13 4 M 0 14600.0000 0.0000 D 2017-02-10 Common Stock 14600.0000 0.0000 D Restricted Share Units 2017-02-13 4 A 0 6036.0000 0.0000 A 2020-02-13 Common Stock 6036.0000 6036.0000 D Awarded under Issuer's Long-Term Incentive Plan. Performance Share Units awarded on February 10, 2014 converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board. Shares earned due to performance factor of 139.9% upon vesting of Performance Share Units and certification of performance results by the Board. Shares withheld for payment of taxes upon vesting of Performance Share Units and certification of performance results by the Board. Shares held in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2017). Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2017). Awarded under Issuer's Long-Term Incentive Plan. Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. Linda E. King, as attorney-in-fact for Michael H. Ullmann 2017-02-15